1346133-39-8

Basic information

• Product Name: N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine
• Synonyms: N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine
• CAS NO: 1346133-39-8
• Molecular Weight: 361.403
• Mol File: 1346133-39-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine(1346133-39-8)
• EPA Substance Registry System: N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine(1346133-39-8)

Safety Data

• Hazardous Substances Data: 1346133-39-8(Hazardous Substances Data)

Upstream product

• 1083325-87-4 7‐bromo‐2‐(1‐methyl‐1H‐pyrazol‐4‐yl)quinoxaline 
• 10272-07-8 3.5-dimethoxyaniline 
• 1346245-04-2 3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinamine 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 82031-32-1 7-bromo-1H-quinoxalin-2-one 
• 1196-57-2 2-hydroxyquinoxaline 
• 82031-32-1 2-hydroxy-7-bromoquinoxaline 
• 1380345-34-5 1-methyl-α-oxo-1H-pyrazole-4-acetaldehyde 
• 97-02-9 2,4-Dinitroanilin 
• 706819-66-1 2-bromo-1-(1-methyl-1H-pyrazol-4-yl)ethan-1-one 
• 55686-94-7 2-Chloro-7-nitroquinoxaline 
• 1346245-03-1 C₁₂H₉N₅O₂ 
• 89891-65-6 7-bromo-2-chloroquinoxaline 

Downstream Products

• 1346248-55-2 C₂₅H₂₉N₅O₃ 
• 1346243-01-3 C₂₁H₂₁N₅O₂ 
• 1346243-67-1 C₂₂H₂₄N₆O₄S 
• 1346243-56-8 N-(3,5-dimethoxyphenyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine 
• 1346243-02-4 C₂₃H₂₅N₅O₂ 
• 1346243-03-5 C₂₄H₂₇N₅O₂ 
• 1346243-37-5 C₂₅H₂₇N₅O₄ 
• 1346243-49-9 C₃₃H₃₈N₆O₄ 
• 1346245-11-1 C₂₉H₃₉N₅O₃Si 
• 1346242-81-6 N¹-(3,5-dimethoxyphenyl)-N²-(1-methylethyl)-N¹-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine 
• 1346243-70-6 C₂₆H₃₂N₅O₅P 
• 1346243-00-2 C₃₂H₃₄N₆O₃ 
• 1346245-72-4 C₃₀H₃₇N₅O₃Si 
• 1346243-51-3 C₂₅H₂₅N₅O₂ 

Relevant articles and documents

Method for preparing erdafitinib

The invention provides a method for preparing erdafitinib. According to the method disclosed by the invention, the reaction step number is only four, and the yield of a halogenation reaction product is high. The synthetic route provided by the invention n

Sodium Butylated Hydroxytoluene: A Functional Group Tolerant, Eco-Friendly Base for Solvent-Free, Pd-Catalysed Amination

NaBHT (sodium 2,6-di-tert-butyl-4-methylphenolate), a strong, but hindered and lipophilic base, has been effectively paired with similarly lipophilic, high-reactivity Pd-NHC (N-heterocyclic carbene) catalysts to produce an ideal combination for performing

Preparation method of Erdafitinib intermediate

The invention discloses a preparation method of an Erdafitinib intermediate 3-(1-methyl-1H-pyrazole-4-yl)-6-quinoxaline amine. The method comprises the steps of by using 2, 4-dinitroaniline as an initial raw material, sequentially carrying out condensation, reduction, cyclization and other basic unit reactions to obtain the target intermediate. The preparation process has the advantages of easilyavailable raw materials, rapidness, convenience, economy and environmental protection, is suitable for large-scale production, and provides a new preparation way for industrialization of Erdafitinib.